Prenatal aspirin at earliest opportunity cuts severe pre-eclampsia risk, study finds
Abstract
Offering aspirin to all pregnant women at the earliest opportunity could reduce severe pre-eclampsia risk by almost one-third, study results have revealed. Presented at the Society for Maternal-Fetal Medicine 2026 Pregnancy Meeting on 11 February 2026, the study compared the outcomes of 18,457 pregnant women whose prenatal care and deliveries took place at Parkland Hospital in Dallas, […]
Fields of Study & Subjects
Pregnancy and preeclampsia studies
Neurological Complications and Syndromes
Pregnancy and Medication Impact
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026
- Language
- EN